Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel prrs virus inducing type i interferon in susceptible cells

a virus and susceptible cell technology, applied in the field of attenuated live viruses, can solve problems such as complicated prrsv infection

Active Publication Date: 2013-01-31
BOEHRINGER LNGELHEIM VETMEDICA GMBH
View PDF2 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text describes a new vaccine and medication for Porcine reproductive and respiratory syndrome (PRRS), a viral disease that affects swine. The invention is based on the use of attenuated live viruses that can prevent or treat the disease. The text describes the process of creating the vaccine and medication, including the use of specific viral proteins and the development of a sequence alignment. The technical effect of the invention is the need for new vaccines and medications that can quickly induce neutralizing antibodies and interferon responses to prevent or treat PRRS.

Problems solved by technology

Often, PRRSV infection is complicated by secondary bacterial infections being attributed to the immunosuppressive nature of the virus.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel prrs virus inducing type i interferon in susceptible cells
  • Novel prrs virus inducing type i interferon in susceptible cells
  • Novel prrs virus inducing type i interferon in susceptible cells

Examples

Experimental program
Comparison scheme
Effect test

examples

[0140]In the examples five viable, genetically designed PRRSV mutant strains are described which are based on infectious EU PRRSV cDNA clone LoN94-13. These strains, delta nsp1 IX-10, delta nsp1 XVII-1, delta nsp1 XVIII-12, delta nsp1 XIX-2 and delta nsp1 XX-9 (henceforth referred to as vaccine candidates), harbor genomic deletions of two, three, four, five, or six codons in their predicted nsp1 genes, respectively, resulting in deletions of two (motif P21R22), three (motif R20P21R22), four (motif G19R20P21R22), five (motif N18G19R20P21R22), or six (motif (P17N18G19R20P21R22) amino acids in their predicted nsp1β proteins, respectively (FIG. 1).

[0141]Based on sequence alignments of parental strain LoN94-13 with PRRSV US and EU reference strains VR-2332 and Lelystad virus as well as with strain GD-XH, the deletions are located in the predicted nsp1β portion of nsp 1 (FIG. 2). In more detail, the deletion site for all vaccine candidates is located in the N-terminal domain (NTD) of nsp1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
volumeaaaaaaaaaa
body temperatureaaaaaaaaaa
Login to View More

Abstract

The present invention relates to the field of attenuated live viruses useful as vaccine or medicament for preventing or treating Porcine Reproductive and Respiratory Syndrome (PRRS) in swine, and is based on the surprising finding of a PRRS virus which is able to induce the interferon type I response of a cell infected by said virus. In one embodiment, the PRRS virus according to the invention is a PRRS virus mutant comprising, in comparison with the genome of a wild type strain, a mutation in the gene encoding the non structural protein 1 (nsp1) of said virus.

Description

SEQUENCE LISTING[0001]The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Jul. 29, 2011 is named 01-2738-SEQ.txt and is 236,320 bytes in size.FIELD OF THE INVENTION[0002]The present invention belongs to the field of vaccines and medicaments for the prophylaxis and treatment of infectious diseases. In particular, it relates to attenuated live viruses useful as vaccine or medicament for preventing or treating Porcine Reproductive and Respiratory Syndrome (PRRS), a viral disease affecting swine.BACKGROUND OF THE INVENTION[0003]Porcine reproductive and respiratory syndrome virus (PRRSV) is a member of the virus family Arteriviridae and belongs, together with the Coronaviridae, to the virus order Nidovirales. PRRSV is an enveloped virus with a single-stranded, positive-sense RNA genome of about 15 kilobases comprising nine open reading frames (ORFs), n...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N7/00C12N7/04C12N15/40C12N15/85C12Q1/70A61P31/14G01N21/55G01N21/64G01N21/78G01N21/75A61K39/12A61P37/04C12N7/01C12N5/10
CPCC07K14/005C12N7/00C12N2770/10062C12N2770/10022C12N2770/10021A61P31/14A61P37/04A61K35/76A61K39/12A61K2039/552C12N2770/10034
Inventor GALLEI, ANDREAS
Owner BOEHRINGER LNGELHEIM VETMEDICA GMBH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com